• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估神经心理状态的可重复性成套测验中的最小临床重要差异。

The Minimum Clinically Important Difference in the Repeatable Battery for the Assessment of Neuropsychological Status.

作者信息

Phillips Rachel, Qi Gao, Collinson Simon Lowes, Ling Audrey, Feng Lei, Cheung Yin Bun, Ng Tze-Pin

机构信息

a Biostatistics Department , Singapore Clinical Research Institute , Singapore , Singapore.

b Gerontological Research Programme, Faculty of Medicine , National University of Singapore , Singapore , Singapore.

出版信息

Clin Neuropsychol. 2015;29(7):905-23. doi: 10.1080/13854046.2015.1107137. Epub 2015 Nov 7.

DOI:10.1080/13854046.2015.1107137
PMID:26548428
Abstract

OBJECTIVE

There is no established minimum clinically important difference (MCID) for the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) index and total scale scores. This study aimed to estimate the MCID for the RBANS index scores and total scale score.

METHOD

Participants included 1,856 ethnic Chinese, older adults. Distribution- and anchor-based methods were used to estimate values for the MCID. Distribution-based estimates were calculated as the standard error of measurement (SEM) and .5 standard deviations (SD). For anchor-based estimates, we compared RBANS scores between the clinical dementia rating (CDR) scale no dementia and very mild dementia groups and between the clinical assessment of dementia (CAD) cognitively normal and mild cognitive impairment groups using regression models adjusting for demographic characteristics.

RESULTS

Estimates from the CDR anchor were 7.79, 8.63, 10.74, 9.74, 5.61, and 3.77 for the total scale score, language, immediate memory, delayed memory, visuospatial/constructional, and the attention index, respectively. Estimates from the distribution-based methods were similar to the estimates based on the CDR, except for the language and attention indexes. Estimates from the CAD anchor were larger.

CONCLUSIONS

We estimated the MCID for the total scale score, language, immediate memory, delayed memory, visuospatial/constructional, and attention indexes of the RBANS as 8, 9, 10, 10, 6, and 4 points, respectively. These estimates are best suited to discriminate between patient groups, for example, in a clinical trial setting. Further research is needed using longitudinal data to assess their applicability to assess within patient differences.

摘要

目的

用于评估神经心理状态的可重复性成套测验(RBANS)指数和总量表分数尚无既定的最小临床重要差异(MCID)。本研究旨在估计RBANS指数分数和总量表分数的MCID。

方法

参与者包括1856名华裔老年人。采用基于分布和锚定的方法来估计MCID值。基于分布的估计值计算为测量标准误(SEM)和0.5个标准差(SD)。对于基于锚定的估计,我们使用调整了人口统计学特征的回归模型,比较了临床痴呆评定量表(CDR)无痴呆组和极轻度痴呆组之间以及痴呆临床评估(CAD)认知正常组和轻度认知障碍组之间的RBANS分数。

结果

CDR锚定法对总量表分数、语言、即时记忆、延迟记忆、视觉空间/结构和注意力指数的估计值分别为7.79、8.63、10.74、9.74、5.61和3.77。基于分布的方法的估计值与基于CDR的估计值相似,但语言和注意力指数除外。CAD锚定法的估计值更大。

结论

我们估计RBANS总量表分数、语言、即时记忆、延迟记忆、视觉空间/结构和注意力指数的MCID分别为8分、9分、10分、10分、6分和4分。这些估计值最适合用于区分患者组,例如在临床试验环境中。需要进一步使用纵向数据进行研究,以评估它们在评估患者内部差异方面的适用性。

相似文献

1
The Minimum Clinically Important Difference in the Repeatable Battery for the Assessment of Neuropsychological Status.用于评估神经心理状态的可重复性成套测验中的最小临床重要差异。
Clin Neuropsychol. 2015;29(7):905-23. doi: 10.1080/13854046.2015.1107137. Epub 2015 Nov 7.
2
Reliable change and minimum clinically important difference (MCID) of the Repeatable Battery for the Assessment of Neuropsychology Status (RBANS) in a heterogeneous dementia sample: Support for reliable change methods but not the MCID.异质性痴呆样本中用于评估神经心理学状态的可重复成套测验(RBANS)的可靠变化及最小临床重要差异(MCID):对可靠变化方法的支持,但对MCID不支持。
Appl Neuropsychol Adult. 2019 May-Jun;26(3):268-274. doi: 10.1080/23279095.2017.1413575. Epub 2018 Jan 10.
3
Predicting Premorbid Scores on the Repeatable Battery for the Assessment of Neuropsychological Status and their Validation in an Elderly Sample.预测用于评估神经心理状态的可重复成套测验的病前分数及其在老年样本中的验证。
Arch Clin Neuropsychol. 2019 May 1;34(3):395-402. doi: 10.1093/arclin/acy050.
4
[The Japanese version of RBANS (Repeatable Battery for the Assessment of Neuropsychological Status)].[RBANS的日文版(用于神经心理状态评估的可重复使用成套测验)]
No To Shinkei. 2002 Jun;54(6):463-71.
5
The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.神经心理学状态评估的可重复性电池作为 HIV 相关神经认知障碍的筛查策略。
AIDS Care. 2021 Mar;33(3):357-363. doi: 10.1080/09540121.2020.1742859. Epub 2020 Mar 17.
6
Discrepancy analysis between crystallized and fluid intelligence tests: a novel method to detect mild cognitive impairment in patients with asymptomatic carotid artery stenosis.晶体智力和流体智力测试之间的差异分析:一种检测无症状颈动脉狭窄患者轻度认知障碍的新方法。
Eur J Neurol. 2018 Feb;25(2):313-319. doi: 10.1111/ene.13504. Epub 2017 Nov 23.
7
The Equivalence and Difference between the English and Chinese Language Versions of the Repeatable Battery for the Assessment of Neuropsychological Status.用于评估神经心理状态的可重复成套测验中英文版本之间的等效性与差异
Clin Neuropsychol. 2015;29 Suppl 1:1-18. doi: 10.1080/13854046.2015.1034182. Epub 2015 Apr 29.
8
The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.重复神经心理状态评估测验 (RBANS):希腊老年人的诊断有效性研究。
Aging Clin Exp Res. 2019 Sep;31(9):1305-1312. doi: 10.1007/s40520-018-1076-9. Epub 2018 Nov 23.
9
[The use of RBANS test (Repeatable Battery for the Assessment of Neuropsychological Status) in neurocognitive testing of patients suffering from schizophrenia and dementia].[RBANS测试(可重复神经心理状态评估量表)在精神分裂症和痴呆症患者神经认知测试中的应用]
Ideggyogy Sz. 2003 Sep 20;56(9-10):303-8.
10
Addenbrooke's cognitive examination III: diagnostic utility for mild cognitive impairment and dementia and correlation with standardized neuropsychological tests.剑桥认知功能检查表第三版:对轻度认知功能障碍和痴呆的诊断效用以及与标准化神经心理学测试的相关性
Int Psychogeriatr. 2017 Jan;29(1):105-113. doi: 10.1017/S1041610216001496. Epub 2016 Sep 29.

引用本文的文献

1
Response to Training in Emotion Recognition Function for Mild TBI/PTSD Survivors: Pilot Study.轻度创伤性脑损伤/创伤后应激障碍幸存者情绪识别功能训练的反应:初步研究
Brain Sci. 2025 Jul 8;15(7):728. doi: 10.3390/brainsci15070728.
2
South Korean study to prevent cognitive impairment and protect brain health through multidomain interventions via face-to-face and video communication platforms in mild cognitive impairment (SUPERBRAIN-MEET): A randomized controlled trial.韩国通过面对面和视频通信平台进行多领域干预预防轻度认知障碍患者认知功能损害及保护脑健康的研究(SUPERBRAIN-MEET):一项随机对照试验
Alzheimers Dement. 2025 Feb;21(2):e14517. doi: 10.1002/alz.14517. Epub 2025 Jan 22.
3
Faecal microbiota transplantation (FMT) in Norwegian outpatients with mild to severe myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): protocol for a 12-month randomised double-blind placebo-controlled trial.
粪便微生物群移植(FMT)在挪威门诊轻度至重度肌痛性脑脊髓炎/慢性疲劳综合征(ME/CFS)患者中的应用:一项为期 12 个月的随机双盲安慰剂对照试验方案。
BMJ Open. 2024 Jun 10;14(6):e073275. doi: 10.1136/bmjopen-2023-073275.
4
Effects of the multidomain intervention with nutritional supplements on cognition and gut microbiome in early symptomatic Alzheimer's disease: a randomized controlled trial.营养补充剂多领域干预对早期有症状阿尔茨海默病认知及肠道微生物群的影响:一项随机对照试验
Front Aging Neurosci. 2023 Nov 2;15:1266955. doi: 10.3389/fnagi.2023.1266955. eCollection 2023.
5
Recent Advances in Neuropsychological Test Interpretation for Clinical Practice.临床实践中神经心理学测试解释的最新进展。
Neuropsychol Rev. 2024 Jun;34(2):637-667. doi: 10.1007/s11065-023-09596-1. Epub 2023 Aug 18.
6
Efficacy and Feasibility of Remote Cognitive Remediation Therapy in Parkinson's Disease: A Randomized Controlled Trial.远程认知康复治疗在帕金森病中的疗效与可行性:一项随机对照试验
Parkinsons Dis. 2023 Jun 1;2023:6645554. doi: 10.1155/2023/6645554. eCollection 2023.
7
Change on the Repeatable Battery for the Assessment of Neuropsychological Status and its relationship to brain amyloid.简易精神状态检查表的变化及其与脑淀粉样蛋白的关系。
J Clin Exp Neuropsychol. 2023 Mar;45(2):105-117. doi: 10.1080/13803395.2023.2216920. Epub 2023 May 24.
8
Comparing the severity of chronic rhinosinusitis symptoms before versus during the COVID-19 pandemic.比较新冠疫情之前与疫情期间慢性鼻窦炎症状的严重程度。
Laryngoscope Investig Otolaryngol. 2022 Oct 25;7(6):1704-1711. doi: 10.1002/lio2.935. eCollection 2022 Dec.
9
Long-term follow-up of patients treated with caplacizumab and safety and efficacy of repeat caplacizumab use: Post-HERCULES study.接受卡普拉珠单抗治疗患者的长期随访:HERCULES 研究。卡普拉珠单抗重复使用的安全性和疗效。
J Thromb Haemost. 2022 Dec;20(12):2810-2822. doi: 10.1111/jth.15892. Epub 2022 Oct 21.
10
Increasing precision in the measurement of change in pediatric neurodegenerative disease.提高儿科神经退行性疾病变化测量的精度。
Mol Genet Metab. 2022 Sep-Oct;137(1-2):201-209. doi: 10.1016/j.ymgme.2022.09.001. Epub 2022 Sep 8.